Kaiseraugst, Switzerland
Kaiseraugst, Switzerland

Time filter

Source Type

News Article | May 11, 2017
Site: cen.acs.org

DSM will invest $25 million in the biobased chemicals firm Amyris and may follow with an additional $25 million in funding. DSM says Amyris’s fermentation technology is a good fit for its health, nutrition, and materials businesses, where consumers want products made from sustainable sources. In the near-term, the two firms will work on health-related products, particularly vitamins and nutritional ingredients. They have an exclusive agreement to develop a low-cost route to vitamin A, which is normally made via chemical synthesis. Amyris and its partner Nenter separately have had success commercializing a process to make vitamin E from Amyris’s key intermediate, farnesene. “Working closely together with Amyris and leveraging DSM’s route-to-market will accelerate our innovation toward cost-effective, fermentation-based processes for both existing and new products,” says Chris Goppelsroeder, president of DSM Nutritional Products. If DSM does invest the full $50 million it will own almost one quarter of Amyris and obtain two seats on its board. Other, unnamed investors have committed an additional $45 million. Amyris will use most of the funds to pay down $75 million in debt. At the end of 2016, it reported long-term debt of more than $128 million and revenues of $67 million. Earlier this month, Amyris reported that sales are up due to growing demand for farnesene used in winter tires. Companies including Sumitomo Rubber Industries are making tires with a farnesene-based rubber said to provide good road grip even in very cold weather. Amyris will report its first-quarter financial results next week.


News Article | May 14, 2017
Site: cen.acs.org

DSM will invest $25 million in the biobased chemicals firm Amyris and may follow with an additional $25 million in funding. DSM says Amyris’s fermentation technology is a good fit for its health, nutrition, and materials businesses, where consumers want products made from sustainable sources. In the near-term, the two firms will work on health-related products, particularly vitamins and nutritional ingredients. They have an exclusive agreement to develop a low-cost route to vitamin A, which is normally made via chemical synthesis. Amyris and its partner Nenter separately have had success commercializing a process to make vitamin E from Amyris’s key intermediate, farnesene. “Working closely together with Amyris and leveraging DSM’s route-to-market will accelerate our innovation toward cost-effective, fermentation-based processes for both existing and new products,” says Chris Goppelsroeder, president of DSM Nutritional Products. If DSM does invest the full $50 million it will own almost one quarter of Amyris and obtain two seats on its board. Other, unnamed investors have committed an additional $45 million. Amyris will use most of the funds to pay down $75 million in debt. At the end of 2016, it reported long-term debt of more than $128 million and revenues of $67 million. Earlier this month, Amyris reported that sales are up due to growing demand for farnesene used in winter tires. Companies including Sumitomo Rubber Industries are making tires with a farnesene-based rubber said to provide good road grip even in very cold weather. Amyris will report its first-quarter financial results next week.


News Article | May 10, 2017
Site: marketersmedia.com

— Market Research Future published a half cooked research report on global Matcha tea market which is estimated to grow more than 5.5% after 2022. Market Overview: Matcha tea specially grown and processed green tea which is finely ground powdered and packed. Matcha tea is rich in vitamin C, chromium, selenium, magnesium and zinc which supports in cholesterol lowering and blood sugar control in turn helping in weight loss. Matcha tea has more antioxidants compared to other tea which is why it is preferred by health cognizant consumers. With the growing healthy lifestyle awareness & their increasing interest in healthy diet, matcha tea is enjoyed as substitute to tea and coffee. Also, with the growth of healthy beverages market and advancement in food technology coupled with the innovation and introduction of organic matcha tea has boosted the sales of matcha teas. Globally, matcha tea market is growing at the rate of 5.5% during 2016 to 2022. Market Forecast: With the growing consumer awareness & their increasing interest in organic food products, the demand for organic matcha tea will drive the market growth from 2016 to 2022. Also, with the growth of food advancement in food technology and packaging technology combined with the innovation and introduction of new flavored matcha teas has boosted the sales of matcha teas. With growing incidence of diseases and increasing consumer health awareness and their consciousness about how they look are the various trends which has led to the adoption of the matcha tea as healthy beverage. These factors will play a key role in the growth of Matcha tea market at the CAGR of 5.5% during 2016-2022. Key Players of Matcha Tea Market: • Tetley GB Ltd (England) • Nestle S.A. (Switzerland) • Tata Global Beverage (India) • DSM Nutritional Products (Netherlands) • Associated British Foods LLC (U.K.) • Unilever Group (U.K.) • Oregon Chai Inc (U.S.) • Northern tea Merchants Ltd. (U.K.) Downstream Analysis: Chocolate matcha tea are enjoyed by consumers across the globe. Rapid globalization and urbanization consumers are aware of various regional flavors, and are interested in consuming regional flavored Matcha tea, furthermore also organic, and preservative free matcha teas personal care product such as lip care, skin care, hair care products are the areas where key players are investing so as to increase the product line based on various regional matcha tea. Growing internet users across the globe and rise in the popularity of e-commerce, key players are launching & promoting their product line on various e-commerce site so as to reach out to various consumers. Market Segmentation: Global Matcha tea market is segmented by type, form, formulation, distribution channel and region. Brief TOC for Matcha Tea: 1 Executive Summary 2 Market Introduction 2.1 Definition 2.2 Scope of the study 2.2.1 Research Objectives 2.2.2 Assumptions 2.2.3 Limitations 2.3 Markets Structure 2.4 Stakeholders 3 Research Methodology 3.1 Research process 3.2 Secondary research 3.3 Primary research 3.4 Forecast model 3.5 Market Size estimation 4 Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Challenges 5 Market Trends 5.1 Trends in Supply/Production 5.2 Trends in Demand/Consumption 5.3 Emerging Markets (Supply & Demand) 5.4 Emerging Brands 5.5 Trade (Import-export) Analysis 5.6 Innovations in Products/Process 5.7 Macroeconomic indicators Analysis for top 5 Producing countries Continue… Regional Analysis: The global Matcha tea market is segmented into North America, Europe, Asia Pacific, and rest of the world (ROW). The market is projected to grow at a steady pace in the review period. Asia-pacific is fastest growing region in the matcha tea market and high growth in emerging economies such as China, India, Japan, Australia, and the Latin American countries, offers ample opportunities for expansion to major players. The high consumption of tea in growing economies of Asia-Pacific and Latin America and growing demand for on-the-go matcha tea infused food products especially in China and India will be the crucial factor underlining the market growth. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR) and Market Research & Consulting Services. MRFR team have the prime objective to provide optimum quality market research and intelligence services to our clients. Our market research studies depending on products, services, technologies, applications, end users, and market players for global, regional, and country level market segments enables our clients to know more consequently do more, which gives them answer for their each and every important question. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with industry experts and does industrial visits for its research analyst members. For more information, please visit https://www.marketresearchfuture.com/


News Article | May 22, 2017
Site: www.prweb.com

Inteligent*Vitamin*C Inc is proud to introduce, by popular demand, the first vitamin C capsule containing nothing but Vitamin C, ALL-C. Normally a non-vitamin C filler is necessary for the capsule-filling machinery to function. ALL-C is the first product known to the company to substitute that filler with a form of vitamin C. The filler used in ALL-C, which is required for manufacturing, is ascorbyl-palmitate – a fat soluble form of vitamin C. Each capsule has 500 milligrams of the world's best vitamin C, and each jar has 120 capsules. ALL-C capsules are Vitamin C Foundation Approved®. The capsule encasing the powdered vitamin C is made from a top-of-the-line organic cellulose. These capsules encase a mix of l-ascorbic acid and sodium ascorbate forms of vitamin C, made by DSM Nutritional Products (formerly Roche) in Darby, Scotland. DSM makes "Quali-C®," a non-GMO, non-Chinese vitamin C. The vitamin C is imported from Scotland, and the capsules are manufactured and assembled by Solara Laboratories in Florida, a new company striving for excellence in supplements. "Inteligent*Vitamin*C is known for providing fine Quali-C® powders that support the high dosages recommended by the late Nobel Prize-winning chemist, Linus Pauling. Normally, added fillers in tablets and capsules make such high dosages problematic. The ALL-C capsules are Inteligent's first capsules that do not use any dose-limiting fillers, " said Robert Fonorow, Vice President of Vitamin C Foundation Approved®. Inteligent*Vitamin*C Inc is confident ALL-C is the best vitamin C capsule to fit consumer needs. This month only, as an introductory offer, buy one jar and get another one free. ALL-C™ is a trademark of Inteligent*Vitamin*C Inc. Vitamin C Foundation Approved® is a registered trademark of the Vitamin C Foundation. Quali-C® is a registered trademark of DSM Nutritional products.


Patent
DSM Nutritional Products AG | Date: 2014-11-18

Disclosed are compositions and methods related to eukaryotic microorganisms that can produce unsaturated fatty acids which can be purified and used.


Patent
Dsm Nutritional Products Ag | Date: 2014-03-13

Disclosed are methods of recovering urea from a urea/oil complex by drying the complex, combining the complex with water to form a urea solution, and removing water from the urea solution. Methods for recycling the urea in urea complexation processes are also disclosed. Also disclosed are methods of recovering polyunsaturated fatty acids or derivatives thereof from the urea/oil complexes.


Patent
DSM Nutritional Products AG | Date: 2014-05-06

Disclosed are methods and compositions related to ONC-T18, D4-desaturases, D5 elongases, their isolation, characterization, production, identification, and use for fatty acid production, as well as organisms containing these compositions and organisms expressing them.


Patent
Dsm Nutritional Products Ag | Date: 2014-12-19

Provided herein are methods of recovering oil from microorganisms. The methods are useful, for example, in obtaining nutritional oils and/or lipid biofuels. The methods of recovering oil described herein include contacting a population of microorganisms with one or more enzymes under conditions that cause disruption of the microorganisms and extracting lipids from the population of microorganisms in the presence of reduced amounts of organic solvent or in the absence of organic solvent.


Patent
Dsm Nutritional Products Ag | Date: 2014-03-12

Provided are Thraustochytrid and Thraustochytrium and relevant methods and reagents, including engineered regulatory sequences and genes from and/or operative in Thraustochytrid or Thraustochytrium, selectable markers useful for engineering microorganisms such as Thraustochytrids, means for mutagenizing microorganisms, strains produced by mutagenesis, and methods and compositions related to production of particular compounds in microorganisms.


Patent
DSM Nutritional Products AG | Date: 2015-08-04

The present disclosure provides, inter alia, Thraustochytrium and relevant methods and reagents, including engineered regulatory sequences from and/or operative in Thraustochytrid or Thraustochytrium, selectable markers useful for engineering microorganisms such as Thraustochytrids, means for mutagenizing microorganisms, novel strains produced by mutagenesis, and methods and compositions related to production of particular compounds in microorganisms.

Loading DSM Nutritional Products AG collaborators
Loading DSM Nutritional Products AG collaborators